Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia.

Authors	Shoji Saito, Chiaki Taira, Kazuyuki Matsuda, Ryu Yanagisawa, Daisuke Morita, Tomonari Shigemura, Kentaro Yoshikawa, Miyuki Tanaka, Kazuo Sakashita, Saki Mukai, Shigetaka Shimodaira, Kenichi Koike, Yozo Nakazawa
Journal	Leukemia & lymphoma (Leuk Lymphoma) Vol. 61 Issue 4 Pg. 967-970 (04 2020) ISSN: 1029-2403 [Electronic] United States
PMID	31809628 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Topics	Acute Disease Child Drug Therapy, Combination Humans Leukemia, Myeloid, Acute (diagnosis, drug therapy) Neoplasm, Residual

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!